The baby medication Optima can help prevent premature birth and prevent death in infants, according to a new study published in the journal Pediatrics.
Optima is a newer medication that has not been tested in humans and is used in a small number of other countries to prevent deaths from the complications of preeclampsia and hypertension.
It works by targeting blood vessels in the placenta and the plasmapheresis that allows oxygen and nutrients to pass from the mother’s blood to the developing fetus, according the University of Illinois Medical Center.
Optimum is the only drug approved for use in pregnant women and was recently approved for treatment of babies, but its use is limited to pregnant women in certain parts of the world.
The research involved 12 women who were treated with Optima during their second trimester.
Those women were followed for 10 months and compared to the other 12 women, according a statement from the U.S. Centers for Disease Control and Prevention.
The study also included 12 women not treated with the medication.
Optimal treatment is based on the fact that Optima has the same effect on the placental circulation as regular anticoagulants, which reduces the chance of an infection, according John Voss, chief medical officer of the Optima Global Healthcare Group, the company that manufactures Optima.
Optimo is currently being tested for side effects in women who have preeclampia, and the results should be available by the end of 2017.
The drug’s approval is in line with what is being done to combat the deadly coronavirus, which is also known as the coronaviruses A and B. The CDC also says that Optimo has shown safety in children under 2 years of age.